These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

691 related items for PubMed ID: 23169419

  • 1. Atypical hydroa vacciniforme-like epstein-barr virus associated T/NK-cell lymphoproliferative disorder.
    Lee HY, Baek JO, Lee JR, Park SH, Jeon IS, Roh JY.
    Am J Dermatopathol; 2012 Dec; 34(8):e119-24. PubMed ID: 23169419
    [Abstract] [Full Text] [Related]

  • 2. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.
    Iwatsuki K, Satoh M, Yamamoto T, Oono T, Morizane S, Ohtsuka M, Xu ZG, Suzuki D, Tsuji K.
    Arch Dermatol; 2006 May; 142(5):587-95. PubMed ID: 16702496
    [Abstract] [Full Text] [Related]

  • 3. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
    Suzuki K, Ohshima K, Karube K, Suzumiya J, Ohga S, Ishihara S, Tamura K, Kikuchi M.
    Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338
    [Abstract] [Full Text] [Related]

  • 4. Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD.
    Ohshima K, Kimura H, Yoshino T, Kim CW, Ko YH, Lee SS, Peh SC, Chan JK, CAEBV Study Group.
    Pathol Int; 2008 Apr; 58(4):209-17. PubMed ID: 18324913
    [Abstract] [Full Text] [Related]

  • 5. Hydroa vacciniforme-like Epstein-Barr virus-associated monoclonal T-lymphoproliferative disorder in a child.
    Wu YH, Chen HC, Hsiao PF, Tu MI, Lin YC, Wang TY.
    Int J Dermatol; 2007 Oct; 46(10):1081-6. PubMed ID: 17910721
    [Abstract] [Full Text] [Related]

  • 6. Hydroa Vacciniforme and Hydroa Vacciniforme-Like Lymphoproliferative Disorder: A Spectrum of Disease Phenotypes Associated with Ultraviolet Irradiation and Chronic Epstein-Barr Virus Infection.
    Chen CC, Chang KC, Medeiros LJ, Lee JY.
    Int J Mol Sci; 2020 Dec 07; 21(23):. PubMed ID: 33297336
    [Abstract] [Full Text] [Related]

  • 7. Common cytological and cytogenetic features of Epstein-Barr virus (EBV)-positive natural killer (NK) cells and cell lines derived from patients with nasal T/NK-cell lymphomas, chronic active EBV infection and hydroa vacciniforme-like eruptions.
    Zhang Y, Nagata H, Ikeuchi T, Mukai H, Oyoshi MK, Demachi A, Morio T, Wakiguchi H, Kimura N, Shimizu N, Yamamoto K.
    Br J Haematol; 2003 Jun 07; 121(5):805-14. PubMed ID: 12780797
    [Abstract] [Full Text] [Related]

  • 8. Hydroa vacciniforme: a distinctive form of Epstein-Barr virus-associated T-cell lymphoproliferative disorders.
    Iwatsuki K, Miyake T, Hirai Y, Yamamoto T.
    Eur J Dermatol; 2019 Feb 01; 29(1):21-28. PubMed ID: 30998212
    [Abstract] [Full Text] [Related]

  • 9. Epstein-Barr virus-associated lymphoproliferative lesions presenting as a hydroa vacciniforme-like eruption: an analysis of six cases.
    Cho KH, Lee SH, Kim CW, Jeon YK, Kwon IH, Cho YJ, Lee SK, Suh DH, Chung JH, Yoon TY, Lee SJ.
    Br J Dermatol; 2004 Aug 01; 151(2):372-80. PubMed ID: 15327544
    [Abstract] [Full Text] [Related]

  • 10. Clonal origin of Epstein-Barr virus (EBV)-infected T/NK-cell subpopulations in EBV-positive T/NK-cell lymphoproliferative disorders of childhood.
    Ohga S, Ishimura M, Yoshimoto G, Miyamoto T, Takada H, Tanaka T, Ohshima K, Ogawa Y, Imadome K, Abe Y, Akashi K, Hara T.
    J Clin Virol; 2011 May 01; 51(1):31-7. PubMed ID: 21377409
    [Abstract] [Full Text] [Related]

  • 11. Epstein - Barr virus positive T and NK-cell lymphoproliferations: Morphological features and differential diagnosis.
    Montes-Mojarro IA, Kim WY, Fend F, Quintanilla-Martinez L.
    Semin Diagn Pathol; 2020 Jan 01; 37(1):32-46. PubMed ID: 31889602
    [Abstract] [Full Text] [Related]

  • 12. Clinicopathological categorization of hydroa vacciniforme-like lymphoproliferative disorder: an analysis of prognostic implications and treatment based on 19 cases.
    Guo N, Chen Y, Wang Y, Huang Y, Feng Y, Li M, Rao H.
    Diagn Pathol; 2019 Jul 17; 14(1):82. PubMed ID: 31315684
    [Abstract] [Full Text] [Related]

  • 13. Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorders.
    Park S, Ko YH.
    J Dermatol; 2014 Jan 17; 41(1):29-39. PubMed ID: 24438142
    [Abstract] [Full Text] [Related]

  • 14. [Delayed diagnosis of hydroa vacciniforme-like lymphoproliferative disorder in a patient with skin rashes].
    Umeki Y, Ikeda M, Nakahara W, Asako M, Matsuoka Y, Terakawa T, Matsunaga H, Tadokoro R, Sekiguchi M, Matsui T, Oka K, Higuchi K, Sawada A, Inoue M, Ueda S.
    Rinsho Ketsueki; 2023 Jan 17; 64(3):209-213. PubMed ID: 37019675
    [Abstract] [Full Text] [Related]

  • 15. EBV-associated cutaneous NK/T-cell lymphoma: review of a series of 14 cases from peru in children and young adults.
    Rodríguez-Pinilla SM, Barrionuevo C, Garcia J, Martínez MT, Pajares R, Montes-Moreno S, Casavilca S, Montes J, Bravo F, Zaharia M, Zevallos-Giampietri E, Sanchez L, Piris MA.
    Am J Surg Pathol; 2010 Dec 17; 34(12):1773-82. PubMed ID: 21107082
    [Abstract] [Full Text] [Related]

  • 16. Clinicopathological categorization of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications.
    Paik JH, Choe JY, Kim H, Lee JO, Kang HJ, Shin HY, Lee DS, Heo DS, Kim CW, Cho KH, Kim TM, Jeon YK.
    Leuk Lymphoma; 2017 Jan 17; 58(1):53-63. PubMed ID: 27157296
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic and disease severity determination criteria for hydroa vacciniforme lymphoproliferative disorders and severe mosquito bite allergy.
    Hirai Y, Asada H, Hamada T, Kawada JI, Kimura H, Arai A, Ohshima K, Ohga S, Iwatsuki K, Committee for Guidelines for the Management of Chronic Active EBV Disease and Related Disorders (the MHLW Research Team in Japan).
    J Dermatol; 2023 Jul 17; 50(7):e198-e205. PubMed ID: 37249004
    [Abstract] [Full Text] [Related]

  • 18. Epstein-Barr virus-positive cytotoxic T-cell lymphoma followed by chronic active Epstein-Barr virus infection-associated T/NK-cell lymphoproliferative disorder: a case report.
    Kato S, Miyata T, Takata K, Shimada S, Ito Y, Tomita A, Elsayed AA, Takahashi E, Asano N, Kinoshita T, Kimura H, Nakamura S.
    Hum Pathol; 2013 Dec 17; 44(12):2849-52. PubMed ID: 24012167
    [Abstract] [Full Text] [Related]

  • 19. Fatal natural killer cell lymphoma arising in a patient with a crop of Epstein-Barr virus-associated disorders.
    Nitta Y, Iwatsuki K, Kimura H, Kojima S, Morishima T, Tsuji K, Oono T.
    Eur J Dermatol; 2005 Dec 17; 15(6):503-6. PubMed ID: 16280311
    [Abstract] [Full Text] [Related]

  • 20. Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders.
    Takahashi E, Ohshima K, Kimura H, Hara K, Suzuki R, Kawa K, Eimoto T, Nakamura S, NK-cell Tumor Study Group.
    Histopathology; 2011 Oct 17; 59(4):660-71. PubMed ID: 22014047
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.